HomeProductsBioactive CompoundsEpigeneticsHIFStreptonigrin
Chemical structure of CAS 3930-19-6

Streptonigrin

In Stock•Starting at $854 for 1 mg•Purity ≥ 98%
CAS No.3930-19-6
MDL No.MFCD00063401
MFC25H22N4O8
MW506.50
InChI KeyPVYJZLYGTZKPJE-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$854In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Streptonigrin is a complex cytotoxic antibiotic derived from *Streptomyces flocculus* or *S. rufochromogenus*. It is used in advanced carcinoma and causes leukopenia. It functions as an antimicrobial and antineoplastic agent, and is a quinolone and pyridine derivative.

CAS No.3930-19-6
Product NameStreptonigrin
Acute ToxicAcute Toxic
Signal Word:Danger
HCode:H300
PCode:P264-P270-P301+P316-P321-P330-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.

Bioorganic & medicinal chemistry • Vol. 22, Issue 4 • 2014
PMID: 24440480PMC: PMC3954981DOI: 10.1016/j.bmc.2013.12.064

A fluopol-ABPP HTS assay to identify PAD inhibitors.

Chemical communications (Cambridge, England) • Vol. 46, Issue 38 • 2010
PMID: 20740228PMC: PMC2943038DOI: 10.1039/c0cc02634d

Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells.

Anti-cancer drugs • Vol. 16, Issue 2 • 2005
PMID: 15655414DOI: 10.1097/00001813-200502000-00008

Antitumor antibiotic streptonigrin and its derivatives as inhibitors of nitric oxide-dependent activation of soluble guanylyl cyclase.

European journal of pharmacology • Vol. 483, Issue 2-3 • 2004
PMID: 14729099DOI: 10.1016/j.ejphar.2003.10.018

Documentation

Similar Products